Relationship Management today announced the release of its thought
leadership report, 2012
US Pharma Insights, which provides the results of its third
annual survey of life sciences decision makers on current challenges,
upcoming business developments, preferred strategies and next generation
technology. Leveraging analysis from three years of responses, the
report delivers a holistic view of present and future trends.
The Shape of Change in Decision Making, Industry Concerns and the
Sustained industry concerns, evolved decision making leadership and new
future strategies top 2012's trends. Aligning with previous years'
responses, 74% of respondents ranked the changing commercial business
model as their first, second or third priority of concern; followed by
regulatory reform (62%) and market access (53%). Additionally, decision
making leadership now sources from executive management for most
technology decisions (46%); and strategy/business development for main
business model/process changes (55%). Further, respondents clearly
defined the following prioritized changes for the near future: increased
focus on market access strategies (64%), primary sales force realignment
(38%) and increased focus on managed markets (35%).
Boosts in Field Centric Tablet Usage, Preference for Apple® Mobile OS
and Noteworthy Social Media Gains
Surveyed executives cite continued focus on field centric tablet usage,
their preferred mobile OS and social media. Eight out of ten (80%)
currently use or will be using tablets, and unsurprisingly, field
sales/account management (61%) account for the most active tablet users.
Further, exactly half selected Apple OS as their favorite mobile
platform. In terms of social media trending, the report underscores
significant increases in usage between 2011 and 2012. LinkedIn (96%) and
Facebook (70%) represent respondents' leading channels with marketing
(64%), PR (42%) and sales (38%) make up the most active departments.
Lastly, despite minor social media budgets, those surveyed exhibited
notable gains according to the report.
"The 2012 US report details exactly how and where our current industry
climate is impacting strategy and operations. Respondents report strong
focus on business model changes, as well as next generation and mobile
technologies," said Angela Miccoli, President of North America, Cegedim
Relationship Management. "In order to further our standing as the leader
in pharma CRM, data and compliance solutions, we strive to consistently
monitor the pulse of the industry, and empower our customers with our
proven insights and expertise."
Cegedim Relationship Management, the global leader in Customer
Relationship Management, Healthcare Data, Regulatory Compliance and
Marketing Solutions for the Life Sciences industry, conducted the
thought leadership survey in during the second half of 2012. Please
click here to access the complete report.
Apple is a registered trademark of Apple Inc. Other company and product
names may be trademarks of their respective owners.
Cegedim Relationship Management is the Life Sciences industry's
leading provider of Customer Relationship Management (CRM)
solutions. Designed specifically for Life Sciences, the company's
innovative business solutions incorporate a thorough understanding
of local, regional and worldwide trends. Cegedim Relationship
Management enables more than 200,000 users in many of the world's
most innovative companies to stay ahead of market challenges. In
addition to CRM, Cegedim Relationship Management also provides
marketing, data optimization and regulatory compliance solutions
in more than 80 countries. Cegedim Relationship Management is part
of the France-based Cegedim S.A. Group.
To learn more, please visit: www.cegedim.com/rm.
Follow Cegedim Relationship Management on LinkedIn
Founded in 1969, Cegedim is a global technology and services
company specializing in the healthcare field. Cegedim supplies
services, technological tools, specialized software, data flow
management services and databases. Its offerings are targeted
notably at healthcare industries, life sciences companies,
healthcare professionals and insurance companies. The world leader
in life sciences CRM, Cegedim is also one of the leading suppliers
of strategic healthcare industry data. Cegedim employs 8,200
people in more than 80 countries and generated revenue of €911
million in 2011. Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.com.
[ Back To NFVZone's Homepage ]